Benserazide Hydrochloride
Pharmaceutical-grade Benserazide Hydrochloride (CAS 14919-77-8), 98–102%, supplied wholesale by Zyntex to licensed producers. Decarboxylase inhibitor API for levodopa combination capsules and tablets. CoA and SDS with every lot.
Description
Benserazide Hydrochloride Product Overview
Benserazide hydrochloride (C10H15N3O5·HCl) is a white to yellowish-white crystalline powder that is freely soluble in water. It is sensitive to moisture and oxidation, so packaging and storage conditions are important.
It has no useful effect on its own. Pharmaceutical companies combine it with Levodopa, usually in a 1:4 ratio, in capsules, dispersible tablets and controlled-release capsules for Parkinson’s disease. In this role it is the alternative to Carbidopa, which is used in other combination products.
Zyntex supplies benserazide hydrochloride from qualified API producers with lot-specific documentation, only to licensed pharmaceutical companies. For another API used in movement disorders, see Biperiden Hydrochloride.
Key Applications of Benserazide Hydrochloride
Main application areas:
💊 Capsules
Combined with levodopa in capsules.
🥤 Dispersible Tablets
Combined with levodopa in dispersible tablets.
⏱️ Controlled Release
Component of modified-release capsules.
🔬 Generic Development
Development and reference material.
Benserazide Hydrochloride Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Benserazide Hydrochloride |
| CAS Number | 14919-77-8 |
| Molecular Formula / Weight | C10H15N3O5·HCl / 293.70 g/mol |
| Assay / Purity | 98.0% – 102.0% (Pharma Grade) |
| Appearance | White to yellowish-white crystalline powder |
| Documents | CoA and SDS with every lot |
⚠️ Safety & Handling: Pharmacologically active substance that may damage fertility or the unborn child. Avoid inhalation of dust and contact with skin and eyes; wear gloves, eye protection and dust protection. Store in tightly closed, light-resistant containers in a cool, dry place. Always consult the Safety Data Sheet (SDS) for full classification and handling instructions.
Frequently Asked Questions
What is the difference between benserazide and carbidopa?
Both are peripheral decarboxylase inhibitors combined with levodopa. They are used in different branded and generic combinations, depending on the market.
Who can purchase this API?
It is supplied only to pharmaceutical companies holding the licenses required for API purchase and use in their country.
How can I get a price and documents?
Prices depend on quantity, packaging and destination. Contact us with your required volume to receive a quotation together with the CoA and SDS.
